StockData
Harrow, Inc. logo

Harrow, Inc. (HROW) stock

HROWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30988% above fair value
$32.16+2.64 (+8.94%)

Close on Nov 18, 2026Market cap $1.21BP/E –Yield –

Harrow free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Harrow's free cash flow for the twelve months ending Jun 30, 2026 was $5.02M, up 97.3% year over year. For fiscal 2025 it was $42.98M. The highest annual figure on record is $42.98M in fiscal 2025.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$42.98M–
FY2024Dec 31, 2024-$23.80M-1099.9%
FY2023Dec 31, 2023$2.38M–
FY2022Dec 31, 2022-$892.00K-127.1%
FY2021Dec 31, 2021$3.30M–
FY2020Dec 31, 2020-$1.96M–
FY2019Dec 31, 2019-$518.00K–
FY2018Dec 31, 2018-$1.08M–
FY2017Dec 31, 2017-$9.58M–
FY2016Dec 31, 2016-$18.10M–
FY2015Dec 31, 2015-$10.15M–
FY2014Dec 31, 2014-$7.23M–
FY2013Dec 31, 2013-$4.46M–
FY2012Dec 31, 2012-$1.92M–
FY2011Dec 31, 2011-$291.16K–
FY2010Dec 31, 2010-$2.30M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$10.25M–
Q1 FY2026Mar 31, 2026-$9.19M-147.1%
Q4 FY2025Dec 31, 2025$8.07M–
Q3 FY2025Sep 30, 2025$16.38M+597.8%
Q2 FY2025Jun 30, 2025-$969.00K–
Q1 FY2025Mar 31, 2025$19.50M–
Q4 FY2024Dec 31, 2024-$18.33M-315.6%
Q3 FY2024Sep 30, 2024$2.35M–
Q2 FY2024Jun 30, 2024-$3.09M-171.6%
Q1 FY2024Mar 31, 2024-$4.72M–
Q4 FY2023Dec 31, 2023$8.50M–
Q3 FY2023Sep 30, 2023-$1.73M–
Q2 FY2023Jun 30, 2023$4.32M-6.2%
Q1 FY2023Mar 31, 2023-$8.71M-1647.1%
Q4 FY2022Dec 31, 2022-$4.59M–
Q3 FY2022Sep 30, 2022-$1.47M–
Q2 FY2022Jun 30, 2022$4.60M+7.2%
Q1 FY2022Mar 31, 2022$563.00K-81.2%
Q4 FY2021Dec 31, 2021-$1.63M–
Q3 FY2021Sep 30, 2021-$2.37M-197.6%
Q2 FY2021Jun 30, 2021$4.29M–
Q1 FY2021Mar 31, 2021$3.00M–
Q4 FY2020Dec 31, 2020-$648.00K-183.8%
Q3 FY2020Sep 30, 2020$2.42M–
Q2 FY2020Jun 30, 2020-$2.97M-703.0%
Q1 FY2020Mar 31, 2020-$770.00K–
Q4 FY2019Dec 31, 2019$773.00K–
Q3 FY2019Sep 30, 2019-$94.00K–
Q2 FY2019Jun 30, 2019$492.00K-51.1%
Q1 FY2019Mar 31, 2019-$1.69M–
Q4 FY2018Dec 31, 2018-$736.00K–
Q3 FY2018Sep 30, 2018-$195.00K–
Q2 FY2018Jun 30, 2018$1.01M–
Q1 FY2018Mar 31, 2018-$1.16M–
Q4 FY2017Dec 31, 2017-$478.00K–
Q3 FY2017Sep 30, 2017-$2.49M–
Q2 FY2017Jun 30, 2017-$2.48M–
Q1 FY2017Mar 31, 2017-$4.13M–
Q4 FY2016Dec 31, 2016-$2.59M–
Q3 FY2016Sep 30, 2016-$4.70M–

More Harrow figures

See a number that looks wrong?